Showing results (1891-1900 of 1,978) with videos related to
Sort By:
Pageof 198
Nature Communications|December 6, 2022
The dynamic clustering of insulin receptor underlies its signaling and is disrupted in insulin resistanceAlessandra Dall'Agnese, Jesse M Platt, Ming M Zheng, et al.Nature Ecology & Evolution|October 18, 2017
Ecological resilience in lakes and the conjunction fallacyBryan M Spears, Martyn N Futter, Erik Jeppesen, et al.Journal of Medicinal Chemistry|September 20, 2002
Discovery and SAR of a novel selective and orally bioavailable nonpeptide classical competitive inhibitor class of protein-tyrosine phosphatase 1BHenrik Sune Andersen, Ole H Olsen, Lars F Iversen, et al.Diabetes Care|June 22, 2024
Effect of Semaglutide on Regression and Progression of Glycemia in People With Overweight or Obesity but Without Diabetes in the SELECT TrialSteven E Kahn, John E Deanfield, Ole Kleist Jeppesen, et al.Proceedings of the National Academy of Sciences of the United States of America|January 11, 2007
Small-molecule agonists for the glucagon-like peptide 1 receptorLotte Bjerre Knudsen, Dan Kiel, Min Teng, et al.Proceedings of the National Academy of Sciences of the United States of America|June 26, 2023
The Rho guanine dissociation inhibitor α inhibits skeletal muscle Rac1 activity and insulin actionLisbeth L V Møller, Mona S Ali, Jonathan Davey, et al.Plos One|February 7, 2019
Association of genetic variants previously implicated in coronary artery disease with age at onset of coronary artery disease requiring revascularizationsCharlotte Andersson, Maria Lukács Krogager, Regitze Kuhr Skals, et al.Lancet (London, England)|October 25, 2025
Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trialJohn Deanfield, A Michael Lincoff, Steven E Kahn, et al.Clinical Nutrition (Edinburgh, Scotland)|October 15, 2014
ESPEN endorsed recommendations. Definition and classification of intestinal failure in adultsLoris Pironi, Jann Arends, Janet Baxter, et al.Psychological Medicine|March 12, 2020
Differential effects of age at illness onset on verbal memory functions in antipsychotic-naïve schizophrenia patients aged 12-43 yearsBirgitte Fagerlund, Christos Pantelis, Jens Richardt Møllegaard Jepsen, et al.Pageof 198